Lyle Arnold has joined Biocept as senior vice president and chief scientific officer and Michael Dunn has joined as senior vice president of corporate development.
Arnold is founder and director of Aegea Biotechnologies and served as vice president of research at Gen-Probe from 2003 to 2009. He has also held senior scientific and management positions at Molecular Biosystems, Genta, Synteni, Incyte Genomics, and Oasis Biosciences. He was also a faculty member in the University of California, San Diego, School of Medicine and a member of the UCSD Cancer Center.
Dunn has been working as a consultant to Biocept for several months. Prior to Biocept, he was vice president and chief business officer of Monogram Biosciences; vice president and chief business officer of Aclara BioSciences; vice president and chief business officer at ActivX Biosciences; and vice president of business development at Aurora Biosciences.
HTG Molecular Diagnostics has tapped John Lubniewski as chief business officer.
Prior to joining HTG, Lubniewski held multiple senior management positions at Ventana Medical Systems. He also served as director of new business development and business unit manager at Corning.
Life Technologies has named Ora Hirsch Pescovitz, executive vice president for medical affairs and health system CEO at the University of Michigan, as a new member of its board of directors.
Pescovitz will replace W. Ann Reynolds, who is retiring after serving on the board for six years.
Pescovitz leads the University of Michigan's Health System, which includes the UM Hospitals and Health Centers, the UM Medical School and its Faculty Group Practice, the clinical services of the UM School of Nursing, and Michigan Health, which helps form partnerships outside the University.
Prior to UM, Pescovitz was executive associate dean for research affairs at Indiana University School of Medicine, president and CEO of Riley Hospital for Children, and interim vice president for research administration at Indiana University.